Increasing Effect and Decreasing Toxicity of TCM treatment for Active Rheumatoid Arthritis: An Evidence-based Evaluation Study
Phase 1
Not yet recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- ITMCTR1900002464
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Compliance with the 2010 ACR/EULAR RA classification criteria;
2. DAS28 3.2 - 5.1;
3. RA patients who Compliance with the syndrome of spleen deficiency and dampness toxic stasis obstruction;
4. Disease course <=24 months;
5. Aged18 to 65 years old;
6. The patient was informed and agreed to participate in the study.
Exclusion Criteria
1. Patients with severe organ disease or mental illness;
2. Patients who are allergic to the drugs involved in the study protocol or who have contraindications.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie TCM's efficacy in modulating cytokine pathways for rheumatoid arthritis?
How does TCM treatment compare to conventional DMARDs in managing active rheumatoid arthritis symptoms and toxicity?
Which biomarkers are associated with TCM response prediction in rheumatoid arthritis patients with specific genetic profiles?
What adverse events are commonly reported in TCM-based therapies for rheumatoid arthritis and how are they managed?
Are there synergistic effects when combining TCM with biologic agents like TNF inhibitors in rheumatoid arthritis treatment?